Cannabis Sativa, is known by many to be a drug associated with many side effects to those who consume it. The drug, which to many is bhang is one amongst other drug on the red list; Drugs prohibited by law.
Lesotho, made history in 2017 as the first country in Africa to authorize the growing of the plant for medicinal use. Now, the country’s drug manufacturing company has received a green light from the European Union [EU] to export the drug for medicinal purposes.
Cannabis Sativa Plant [Bhang] authorized by Lesotho for export to Europe. PHOTO|COURTESY
MG Health [Name of the firm] made the announcement this week [Thursday] saying that they had received an official authorization to export the product in the form of an Active Pharmaceutical Ingredient [API] to Germany and other parts of Europe.
The firm’s Chief executive was quoted by BBC&Reuters while making the announcement, revealing that, the first shipment will kick off in June of this year. Now, that Lesotho has made the move, what is your opinion in as far as the authorization is concerned, And if at all you believe in the drug’s medicinal value, Do you think Lesotho could convince other African Countries to follow suit? LEAVE YOUR COMMENTS
Content created and supplied by: TopNewsKe (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More